Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Sumitomo Metal reveals hypoglycemic/hypolipidemic agents

March 3, 1997

Genzyme Transgenics produces protential diabetes Rx in mouse milk

Feb. 28, 1997

Preliminary clinical data reported for OP-1

Feb. 26, 1997

Lilly claims compounds for postmenopausal syndrome

Feb. 26, 1997

Hemosol's blood substitute advances to phase II

Feb. 25, 1997

Agents for infertility described by Novo Nordisk

Feb. 25, 1997

GH-releasing peptides from Novo Nordisk

Feb. 25, 1997

Novo Nordisk's growth hormone now available in 67 countries

Feb. 24, 1997

Merck's Fosamax earns recommendation

Feb. 24, 1997

SKB prepares chimeric leptins

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...